Over the years the European Medicines Regulatory Network has collected a wealth of data about clinical trials through their clinical trials registers, CTIS and EudraCT.
These data are used to support regulatory decision-making, though their potential uses extend far beyond that scope. Stakeholders may have diverse interests, from locating trials for certain health conditions to monitoring innovation in healthcare and even applying Artificial Intelligence for novel insights. While these data hold immense potential, they still pose challenges in access and usability.
Aiming to overcome these challenges, the initiative engaged stakeholders via a workshop to understand how data about clinical trials can address their needs. The workshop will result in the publication of a research agenda on clinical trial analytics which will guide regulatory action and may influence future public funding calls.
By highlighting research needs and facilitating analysis of clinical trial data, ACT EU will help address key challenges in the EU clinical trials environment.
